Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Melanoma 27Neoplasm Metastasis 16Skin Neoplasms 12Breast Neoplasms 9Multiple Myeloma 8Kidney Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Pancreatic Neoplasms 7Ovarian Neoplasms 7Lymphoma 7Leukemia, Lymphocytic, Chronic, B-Cell 7Leukemia 7Hematologic Neoplasms 7Neoplasms 6Myelodysplastic Syndromes 6Leukemia, Myeloid, Acute 6Uterine Cervical Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma, B-Cell 5Carcinoma, Non-Small-Cell Lung 5Urogenital Neoplasms 4Stomach Neoplasms 3Lung Neoplasms 3Liver Neoplasms 3Gastrointestinal Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Carcinoma, Renal Cell 3Vaginal Neoplasms 2Rectal Neoplasms 2

Interventions

tanespimycin 4fludarabine phosphate 4Magnetic Resonance Spectroscopy 4Cyclosporine 4Biopsy 4aldesleukin 3Vorinostat 3Specimen Handling 3Polymerase Chain Reaction 3Peripheral Blood Stem Cell Transplantation 3Irinotecan 3Gemcitabine 3Flow Cytometry 3Bortezomib 3romidepsin 2pembrolizumab 2nelarabine 2mogamulizumab 2laromustine 2entinostat 2belinostat 2alvocidib 2Psychiatric Rehabilitation 2Pharmacogenomic Testing 2Nivolumab 2Methylprednisolone 2MK 2206 2Levofloxacin 2Lenalidomide 2Interleukin-15 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Sezary Syndrome × fludarabine × Clear all
NCT00047060 2023-11-14

Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
5 enrolled 18 charts
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡